SCHEMBL10123588

SCHEMBL10123588

CC(F)(F)C(C)(NC(=O)N1CCC(c2ccccc2)CC1)C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.50
HSD11B1 P28845 1/20 0.49
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
TP53 P04637 4/20 0.47
KCNH2 Q12809 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
CHRM4 P08173 1/20 0.46
RORC P51449 1/20 0.45
NAMPT P43490 1/20 0.44
RBP4 P02753 3/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
CHRM2 P08172 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122318 0.95 NPC1 (0.52) NPC1HSD11B1RAB9ASMN1; SMN2TP53
SCHEMBL10123536 0.79 MAPK1 (0.56) SMN1; SMN2TP53RBP4CYP2C19MAPT
SCHEMBL10123504 0.78 LMNA (0.45) NPC1RAB9ASMN1; SMN2CYP2C19MAPT
SCHEMBL13993504 0.74 GAA (0.45) NPC1RAB9ASMN1; SMN2HTTEPHX2
SCHEMBL571141 0.73 KDM1A (0.60) NPC1HSD11B1RAB9ASMN1; SMN2TP53
SCHEMBL13328860 0.73 RIPK1 (0.58) NPC1HSD11B1RAB9ASMN1; SMN2TP53
SCHEMBL10122256 0.73 MAPK1 (0.58) SMN1; SMN2TP53RBP4CYP2C19MAPT
SCHEMBL10123383 0.73 GAA (0.44) NPC1RAB9ASMN1; SMN2CYP2C19HTT
SCHEMBL10123579 0.73 GAA (0.44) NPC1RAB9ASMN1; SMN2CYP2C19HTT
SCHEMBL17530362 0.72 NPC1 (0.46) NPC1HSD11B1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012060820-A1 SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2012-05-10 WO disclosed